Danish life science companies look to the UK in spite of Brexit
Although the upcoming British departure from the EU creates uncertainty about the future of the British market, Danish life science companies are nevertheless reinforcing their commercial activities in the UK – because Brexit could also create new opportunities.
BY ELIZABETH MØNSTED JOHANSEN
Although the British goodbye to the European Union – or Brexit, as it has been dubbed – has turned the British market and its potential pitfalls and opportunities upside down, it does not seem to have put of Danish companies in the life science industries.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Brexit could cause long-term headache for Novo Nordisk
For abonnenter
Össur buys british prosthetics group
For abonnenter
